Tech, defence, energy: Key agenda for Modi-Biden talks

Prime Minister Narendra Modi and United States President Joe Biden during their talks next week are expected to touch on five broad areas of significance -- healthcare, technology, renewable......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

ICMR, Hyderabad co develop potential treatment for COVID-19

The Indian Council of Medical Research (ICMR) in collaboration with a Hyderabad-based biopharmaceutical company has developed 'highly purified antisera' prepared by injecting inactivated......

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......

Peregrine plans cancer drug trial in India

US drug research major Peregrine Pharmaceuticals Inc will conduct trials of its latest brain cancer drug-Cotara in India. The safety and efficacy study of this drug at seven clinical centres in the......

Actis plans research arm, multiple JVs

US-based biopharmaceutical company Actis Biologics Inc is setting up its wholly owned subsidiary in India in a move to make the country a hub for its clinical research and developmental......

TIL to pump $350 mn into global start-ups

Tata Industries, a promoter company of the Tata group, is ready to invest up to $350 million (about Rs 1,500 crore) in international start-up businesses. "We are looking at breakthrough......

Intas to create clones for protein production

Intas Biopharmaceuticals Ltd (IBPL) plans to generate clones for commercial production of protein. The company has finalised a Research and Development (R&D) agreement for the development and......